| Title | Authors | Date Published | ||
|---|---|---|---|---|
| Improvements in brain and behavior following eradication of hepatitis C. | T. Kuhn, P. Sayegh, J.D. Jones, J. Smith, M.K. Sarma, A. Ragin, E.J. Singer, A. Thomas, A.D. Thames, S.A. Castellon, C.H. Hinkin | 2017 08 | Journal Article | |
| Dopamine Increases CD14CD16 Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis. | T.M. Calderon, D.W. Williams, L. Lopez, E.A. Eugenin, L. Cheney, P.J. Gaskill, M. Veenstra, K. Anastos, S. Morgello, J.W. Berman | 2017 06 | Journal Article | |
| HIV-Associated Cardiovascular Disease: Role of Connexin 43. | L. Prevedel, C. Morocho, M.V.L. Bennett, E.A. Eugenin | 2017 Sep | Journal Article | |
| Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS. | S. Malik, E.A. Eugenin | 09/2017 | Journal Article | |
| HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim | P. Castellano, L. Prevedel, E.A. Eugenin | 10/2017 | Journal Article | |
| Tunneling nanotubes (TNT) mediate long-range gap junctional communication: Implications for HIV cell to cell spread | G. Okafo, L. Prevedel, E.A. Eugenin | 11/2017 | Journal Article | |
| Connexin43 Containing Gap Junction Channels Facilitate HIV Bystander Toxicity: Implications in NeuroHIV. | S. Malik, M. Theis, E.A. Eugenin | 2017 | Journal Article | |
| CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS | M. Veenstra, D.W. Williams, T.M. Calderon, K. Anastos, S. Morgello, J.W. Berman | 11/2017 | Journal Article | |
| Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. | M. Gonzalez-Perez, P.J. Peters, O. O'Connell, N. Silva, C. Harbison, S.Cummings Macri, S. Kaliyaperumal, K. Luzuriaga, P.R. Clapham | 2017 10 15 | Journal Article | |
| Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy. | A.M. Anderson, J.A. Muñoz-Moreno, D.R. McClernon, R.J. Ellis, D. Cookson, D.B. Clifford, A.C. Collier, B.B. Gelman, C.M. Marra, J.C. McArthur, A. McCutchan, S. Morgello, N. Sacktor, D.M. Simpson, D.R. Franklin, R.K. Heaton, I. Grant, S.L. Letendre | 2017 Jan 01 | Journal Article | |
| Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. | P. Jia, Z. Zhao, T. Hulgan, W.S. Bush, D.C. Samuels, C.S. Bloss, R.K. Heaton, R.J. Ellis, N. Schork, C.M. Marra, A.C. Collier, D.B. Clifford, B.B. Gelman, N. Sacktor, S. Morgello, D.M. Simpson, A. McCutchan, J.S. Barnholtz-Sloan, D.R. Franklin, D. Rosario, S.L. Letendre, I. Grant, A.R. Kallianpur | 2017 Jun | Journal Article | |
| Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. | S.R. Mehta, J. Pérez-Santiago, T. Hulgan, T.R.C. Day, J. Barnholtz-Sloan, H. Gittleman, S. Letendre, R. Ellis, R. Heaton, S. Patton, J.D. Suben, D. Franklin, D. Rosario, D.B. Clifford, A.C. Collier, C.M. Marra, B.B. Gelman, J. McArthur, A. McCutchan, S. Morgello, D. Simpson, J. Connor, I. Grant, A. Kallianpur | 2017 03 31 | Journal Article | |
| Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND. | L.C. Obermeit, J. Beltran, K.B. Casaletto, D.R. Franklin, S. Letendre, R. Ellis, C. Fennema-Notestine, F. Vaida, A.C. Collier, C.M. Marra, D. Clifford, B. Gelman, N. Sacktor, S. Morgello, D. Simpson, A. McCutchan, I. Grant, R.K. Heaton | 2017 02 | Journal Article | |
| Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. | S.M. Patton, Q. Wang, T. Hulgan, J.R. Connor, P. Jia, Z. Zhao, S.L. Letendre, R.J. Ellis, W.S. Bush, D.C. Samuels, D.R. Franklin, H. Kaur, J. Iudicello, I. Grant, A.R. Kallianpur | 2017 Apr 21 | Journal Article | |
| Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection. | T. Yuen, M.J. Brouillette, L.K. Fellows, R.J. Ellis, S. Letendre, R. Heaton, N. Mayo | 2017 09 01 | Journal Article | |
| HIV Distal Neuropathic Pain Is Associated with Smaller Ventral Posterior Cingulate Cortex. | J.R. Keltner, C.G. Connolly, F. Vaida, M. Jenkinson, C. Fennema-Notestine, S.L. Archibald, C. Akkari, A. Schlein, J. Lee, D. Wang, S. Kim, H. Li, A. Rennels, D.J. Miller, G. Kesidis, D. Franklin, C. Sanders, S. Corkran, I. Grant, G.G. Brown, J.H. Atkinson, R.J. Ellis | 2017 03 01 | Journal Article | |
| Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. | C. Ubaida-Mohien, B. Lamberty, A.M. Dickens, M.M. Mielke, T.D. Marcotte, N. Sacktor, I. Grant, S. Letendre, D. Franklin, P. Cibrowski, R. Tharakan, J.C. McArthur, H.S. Fox, N.J. Haughey | 2017 06 19 | Journal Article | |
| Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation. | P. Curley, R.K.R. Rajoli, D.M. Moss, N.J. Liptrott, S. Letendre, A. Owen, M. Siccardi | 2017 01 | Journal Article |
| Title | Authors | Date Published | ||
|---|---|---|---|---|
| CNS iron status is associated with neurocognitive function over time in HIV+ adults | H. Kaur, W. Bush, S. Letendre, R. Ellis, R. Heaton, S. Patton, C. J, D. Samuels, T. Hulgan, A. Kallianpur | Presentation | ||
| Cerebral volumetric and metabolic abnormalities in HIV associated neurocognitive disorders (HAND) | A. Alakkas, R. Ellis, W. Watson, R. Heaton, S. Letendre, A. Collier, C. Marra, D. Clifford, B. Gelmen, N.C. Sacktor, S. Morgello, D. Simpson, A. McCutchan, A. Kallianpur, S. Gianella, F. Vaida, T. Marcotte, I. Grant, C. Fennema-Notestine | Presentation |